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T cell repertoire diversity and clonotype follow-up in vaccination, cancer, infectious and
immune diseases represent a major challenge owing to the enormous complexity of the data
generated. Here we describe a next generation methodology, which combines 50RACE PCR,
454 sequencing and, for analysis, IMGT, the international ImMunoGeneTics information
system (IMGT), IMGT/HighV-QUEST web portal and IMGT-ONTOLOGY concepts. The
approach is validated in a human case study of T cell receptor beta (TRB) repertoire, by
chronologically tracking the effects of influenza vaccination on conventional and regulatory
T cell subpopulations. The IMGT/HighV-QUEST paradigm defines standards for genotype/
haplotype analysis and characterization of IMGT clonotypes for clonal diversity and expres-
sion and achieves a degree of resolution for next generation sequencing verifiable by the user
at the sequence level, while providing a normalized reference immunoprofile for human TRB.
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T
he T cell receptor (TR)1 is critical for peptide/major
histocompatibility (pMH) recognition. The TR repertoire
is vast, with direct estimates of 2.5 107 unique ab TR per
individual2 and significantly higher numbers by theoretical
calculations3. The ab TR is a membrane-bound, clonotypic,
heterodimeric protein comprising one alpha chain (TRA) and
one beta chain (TRB)1. Each chain comprises a variable (V)
domain and a constant (C) region that includes a C domain and
connecting, transmembrane and cytoplasmic regions. The
V-ALPHA domain results from the rearrangement between a
TRAV gene and a joining J (TRAJ) gene, whereas the V-BETA
domain results from the rearrangement of a TRBV gene, a
diversity D (TRBD) gene and a joining J (TRBJ) gene. The C
region of the TR chains is encoded by the TRAC and TRBC
(TRBC1 and TRBC2) genes, respectively1. Each V domain
comprises three highly flexible complementarity-determining
regions (CDR) at the antigen-binding face of the receptor1.
When docking its cognate pMH ligand, the CDR1 and CDR2
facilitate binding of the receptor to the MH helices, while CDR3
principally engages the peptide within the MH groove4,5. The
specificity of the TR predominantly depends on the CDR3 created
by the V-(D)-J rearrangement.
It remains a significant challenge to understand the diversity
and specificity of T cells, particularly during natural infection.
The approach by tetramer staining or antigen-induced cytokine
release6–11 is limited by our knowledge of mapped epitopes.
Classical DNA cloning and Sanger sequencing techniques are
laborious and generally limit data to a few hundred, or in rare
cases a few thousand, TR sequences per investigation6–9. The
complexity and depth of the human TR repertoire was recently
explored in several studies using next generation sequencing
(NGS)12–20. In these studies, Illumina sequencing was primarily
used, with a major advantage of generating very deep data, but a
disadvantage that the read length was short and the data either
required assembly12,13 or focused exclusively on the CDR3 (refs
14,15). 454 sequencing was also used previously16,17,19,20 but only
in combination with multiplex PCR. Earlier studies also explored
various bioinformatic tools but different algorithms added
potential layers of discrepancy. ImMunoGeneTics (IMGT)/
HighV-QUEST21,22 (http://www.imgt.org) is the authentic high
throughput version of the IMGT/V-QUEST tool23–25 (acknowledged
as the international reference for immunoglobulin and TR
sequence analysis, CSH Protocols, WHO/IUIS). IMGT/HighV-
QUEST uses the same algorithm as IMGT/V-QUEST and
achieves the same degree of resolution and high quality results.
We now introduce a high throughput methodology for a
standardized comparative TR analysis on the basis of IMGT-
ONTOLOGY concepts. This approach consists of 50 rapid
amplification of cDNA ends (RACE)12,26 to avoid amplification
bias associated with multiplex PCR, 454 sequencing to bypass
the limitations of short-read assembly and IMGT/HighV-
QUEST analysis21,22 to ensure the highest quality in sequence
interpretation of full-length rearranged human TR V-BETA
transcripts. We illustrate the usefulness and application of this
methodology by the analysis of the human TR repertoire response
towards a model immune challenge, the H1N1 vaccine. IMGT/
HighV-QUEST was recently released21, and this report represents
its official initial reference for application in high throughput TR
repertoire and IMGT clonotype analysis.
Results
Workflow results. A model immune challenge was provided by
vaccinating a healthy volunteer with a H1N1 influenza vaccine.
Three T cell subpopulations (‘CD4 ’, ‘CD4þ ’ and ‘Treg’27–30)
were isolated by flow cytometry, at four time points (baseline and
days 3, 8 and 26 post vaccination) (Fig. 1a). Twelve amplicon
libraries of the corresponding TR trancripts were prepared using
anchored 50RACE PCR12 and a TRBC gene-specific reverse
primer1,31 (Supplementary Table S1). Sequencing was performed
using 454 technology, which is appropriate for 4400 nt long
sequences. During the platform-specific data processing, 160,944
reads passed the 454 pipeline filter (the pass rate was 46.73%), but
7,405 of these were later discarded owing to missing or incom-
plete barcodes. Therefore, we obtained 153,539 ‘final 454-output’
reads for the 12 samples, of which 72% exceeded 300 nt. These
reads were directly analysed by IMGT/HighV-QUEST, without
the need for computational read assembly.
As IMGT/HighV-QUEST currently accepts up to 150,000
sequences per job, the final 454-output 50 reads (79,564 ‘MIDA_all’)
and 30 reads (73,975 ‘MIDB_all’) were submitted separately
(Supplementary Fig. S1). Online statistical analyses (IMGT/
HighV-QUEST currently accepts up to 450,000 results of
analysed sequences per statistical run) were performed on the
pooled results of the two jobs ‘MIDA_all’ and ‘MIDB_all’, and on
the combined 50 þ 30 reads of each of the 12 samples (designated
as sets, for example, MID1 (Supplementary Table S1)). An
additional level of expertise was specifically developed during
this study to define and characterize individual IMGT clono-
types unambiguously from NGS data (clonal diversity) and
determine the precise number of sequences assigned to each
clonotype (clonal expression). This approach is on the basis of
IMGT-ONTOLOGY32,33 and more specifically on the concepts
of classification (gene and allele nomenclature)34, description
(standardized labels)35 and numerotation (IMGT unique
numbering)36–38.
IMGT/HighV-QUEST summary. The IMGT/HighV-QUEST
‘Summary’ of the statistical analysis (Fig. 2) made on ‘MIDAþ
MIDB’ (pooled results of the two jobs ‘MIDA_all’ and ‘MID-
B_all’) shows that, of the 153,539 submitted sequences, 63,371
were categorized as ‘1 copy’ and 867 were categorized as ‘More
than 1’. These sequences were filtered-in for statistical analysis
(64,238 sequences, 41.84% of the submitted sequences), whereas
sequences not answering the required criteria (e.g., ‘No results’,
‘Unknown functionality’) were filtered out21 (Supplementary Fig.
S1). The ‘1 copy’ category (63,371, 98.65% of the filtered-in
sequences) comprises the sequences to be analysed in detail (this
category avoids repeating the same analysis on strictly identical
sequences, which are stored instead in ‘More than 1’)
(Supplementary Fig. S1). NGS ‘1 copy’ is not synonymous of
‘clonotype’: indeed, several ‘1 copy’ sequences may correspond to
a single clonotype if the sequences only differ in their length and/
or due to sequencing errors. One of the aims of this work was
therefore to define, identify and characterize the distinct clono-
types from this ‘1 copy’ category, and thus to be able to evaluate
the true clonal diversity.
IMGT/HighV-QUEST is a generic tool, and the ‘More than 1’
category is designed for expression studies, in experiments with
well-controlled parameters. Indeed, for each ‘1 copy’ sequence,
the tool provides the number of ‘More than 1’ sequences (867
sequences, Fig. 2; Supplementary Fig. S1). A second aim of this
work was therefore to assign, to each distinct clonotype, all the
relevant ‘1 copy’ sequences, as well as the number of their
corresponding ‘More than 1’, and thus to be able to provide the
framework to evaluate the clonal expression.
IMGT/HighV-QUEST detailed statistical analysis is performed
on the ‘1 copy’ sequences. These sequences have an average
length of 431 nt (Fig. 2) but the length of the V domain (V-D-J-
REGION) within each sequence may vary. With the longer
V-D-J-REGION, IMGT/HighV-QUEST identifies a single allele,
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unambiguously, whereas with the shorter V-D-J-REGION, the
tool proposes several solutions. The ‘1 copy’ therefore comprises
two categories: ‘single allele’ (one allele for V and J) and ‘several
alleles (or genes)’ (several alleles for V and/or J) (Supplementary
Fig. S1). In this study, the ‘single allele’ (for V and J) comprised
58,958 sequences (91.78% of the filtered-in sequences, average
length 440 nt), with a V-D-J-REGION average length of 335 nt,
whereas the ‘several alleles (or genes)’ (for V and/or J) comprised
4,413 sequences (6.87% of the filtered-in sequences, average
length 309 nt) with a V-D-J-REGION average length ofB250 nt.
Most of the ‘single allele’ sequences contained a complete V
domain, with many even containing the leader region (L-
REGION) or part of it (checked with the individual sequence
files). We consider the sequences of the ‘single allele’ category to
be superior to those of the ‘several alleles (or genes)’ category in
terms of biological interpretations.
IMGT/HighV-QUEST analysis is performed by default with
the option of accepting insertions and/or deletions (indels) that
looks for indels in the V-REGION and corrects these before
characterizing the sequences22,25. More than 38% (38.41%) of the
filtered-in sequences (24,674 sequences out of 64,238, Fig. 2) were
detected by IMGT/HighV-QUEST as having indels. Most, if not
all, of these indels correspond to sequencing errors and therefore
the corresponding sequences corrected by IMGT/HighV-QUEST
could be included in the final results, as they had no other
anomaly. The IMGT/HighV-QUEST option of accepting inser-
tions and/or deletions is therefore particularly appropriate for the
454 sequencing of TR. Analysis without that option would have
led these sequences being assigned to one of the filtered-out
categories or to an erroneous sequence characterization.
TRB genotype and haplotype identification. The TRBV, TRBD
and TRBJ gene and allele usage was obtained using the statistical
analysis of IMGT/HighV-QUEST available online21. This analysis
is performed automatically on the ‘1 copy’ ‘single allele’ (for V
and J) category (Supplementary Fig. S1). A total of 55 TRBV
genes (47 functional F, 1F/open reading frame (ORF), 3 ORF, 4
pseudogenes) were identified in the rearrangements. This
includes the TRBV6-3 gene as discussed below. The presence of
rearranged transcripts for four in-frame pseudogenes TRBV1,
TRBV3-2, TRBV12-1 and TRBV21-1 was rather unexpected
(Fig. 3a), but consistent with the selection of the IMGT/V-
QUEST directory ‘FþORFþ in-frame P’ for the analysis (Fig. 2).
These pseudogenes were found with in-frame or out-of-frame
junction rearrangements. Although a limited number of ‘1 copy’
‘single allele’ for two of these pseudogenes was observed (three for
TRBV1 and two for TRBV12-1; Fig. 3a), the fact that they were
found in different sets with different junctions underline the
quality of the data and confirmed that no TRBV gene was over-
looked in the 50RACE amplification step. The TRBV3-2 and
TRBV21-1 in-frame pseudogenes were found in 105 sequences
(56 for allele TRBV3-2*01 and 49 for allele TRBV3-2*03) and 549
sequences, respectively (Fig. 3a). In contrast, two other in-frame
pseudogenes (TRBV12-2 and TRBV26) and two ORF (TRBV7-1
and TRBV17) were not found (Fig. 3a).
For the first time, the TRBV genotype and haplotypes of an
individual could be identified unambiguously from the gene and
allele usage (Supplementary Table S2). The apparent ‘absence’ of
the functional TRBV6-3 gene was expected as its allele TRBV6-
3*01 has an identical sequence to TRBV6-2*01 (the IMGT/
HighV-QUEST ‘1 copy’ results therefore include TRBV6-3*01
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Figure 1 | Flow cytometry and generation of the final amplicon library. (a) Sorting gate. The initial gates were set on lymphocytes based on side
scatter (SSC) and forward scatter (FSC), from which the CD3 T cell gate (left panel) was set. Within the CD3 gate, we firstly gated for CD3þCD25þ
CD127 /lo natural Treg (‘Treg’) cell population (middle panel) and the remaining CD3þ T cells were divided into CD3þCD4þ (‘CD4þ ’) and CD3þ
CD4 (‘CD4 ’) conventional T cells (right panel). (b) Gel appearance of the final purified amplicon library. RNA was purified from sorted cells
representing the 12 samples (corresponding to three Tcell subpopulations at the four time points) and TRB V-D-J transcripts were amplified, independently,
through 50RACE and PCR and barcodes incorporated in a second PCR. The products were purified and an equal amount (100 ng) of cDNA from each
of the 12 reactions was pooled. The final amplicon library appeared as a band between 550 and 650bp.
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under ‘TRBV6-2*01). The TRBV6-3 gene was taken into account
in the genotype identification (Supplementary Table S2), although
it cannot be displayed in the histogram (Fig. 3a). No other similar
case was detected.
The individual is homozygous for most functional TRBV genes,
except for 2, for which he is heterozygous, namely TRBV20-1
(alleles *01 and *02) and TRBV7-3 (allele *01 functional and
allele *02 ORF). The TRBV genes for which the individual is
homozygous have the allele *01, except for three genes, which
have the allele *02 (TRBV5-5*02, TRBV15*02 and TRBV30*02).
The frequently used V genes are distributed along the TR locus at
uneven intervals (Fig. 3a).
The 2 TRBD genes (Fig. 3b) and all 13 functional TRBJ genes
(Fig. 3c) were detected in this analysis. As for the TRBV genes,
the TRBD and TRBJ genotype and haplotypes were identified on
the basis of the alleles identified by IMGT/HighV-QUEST. The
individual is heterozygous for TRBD2 (TRBD2*01/TRBD2*02)
and TRBJ1-6 (TRBJ1-6*01/TRBJ1-6*02) and homozygous for
TRBD1 and the other TRBJ genes (all *01).
Thus, the histograms and tables of the IMGT/HighV-QUEST
statistical analysis of the TRBV, TRBD and TRBJ gene and allele
usage, performed on the ‘1 copy’ ‘single allele’ (for V and J)
category, provides an accurate genotype landscape of this
individual. Moreover, for the first time, and based on the
unambiguous TRBV, TRBD and TRBJ allele determination in
V-D-J rearrangements, haplotypes could be described for NGS
data. Thus, we demonstrated the respective linkage of the
TRBV20-1*01 and TRBJ1-6*01 (and also TRBD2*02) on one
chromosome, and of the TRBV20-1*02 and TRBJ1-6*02 (and also
TRBD2*01) on the other. No such linkage could be obtained for
the TRBV7-3 alleles because no rearrangement was found to
TRBJ1-6.
These results on the V, D and J genes and alleles provide
important clues for the interpretation of sequences of the ‘1 copy’
‘several alleles’ (for V and/or J) category. They also represent a
crucial step towards the definition and characterization of IMGT
clonotypes for an accurate description of repertoire immunopro-
files, as described below.
IMGT clonotype definition and characterization. In the litera-
ture, clonotypes are defined differently, depending on the
experiment design (functional specificity) or available data. Thus,
a clonotype may denote either a complete receptor (e.g., TR
alpha-beta), or only one of the two chains of the receptor (e.g.,
TRA or TRB), or one domain (e.g., V-BETA), or the CDR3
sequence of a domain. Moreover the sequence can be at the
amino acid (AA) or nucleotide level, and this is rarely specified.
Therefore, our priority was to define clonotypes and their prop-
erties, which could be identified and characterized by IMGT/
HighV-QUEST, unambiguously.
In IMGT, the clonotype, designated as ‘IMGT clonotype (AA)’,
is defined by a unique V-(D)-J rearrangement (with IMGT gene
and allele names determined by IMGT/HighV-QUEST at the
nucleotide level21–25) and a unique CDR3-IMGT AA (in-frame)
junction sequence39–41. To identify ‘IMGT clonotypes (AA)’ in a
given IMGT/HighV-QUEST data set, the ‘1 copy’ are filtered to
select for sequences with in-frame junction, conserved anchors
104 and 118 ‘C, F’ (‘C’ is 2nd-CYS 104, and ‘F’ is the J-PHE 118 of
V-BETA)36–38 and for V and J functional or ORF, and ‘single
allele’ (for V and J; Supplementary Fig. S1).
By definition, an ‘IMGT clonotype (AA)’ is ‘unique’ for a given
data set (Fig. 4a). Consequently, each ‘IMGT clonotype (AA)’, in
a given data set, has a unique set identifier (column ‘Exp. ID’)
and, importantly, has a unique representative sequence (link in
column ‘Sequence ID’) selected by IMGT/HighV-QUEST among
the ‘1 copy’ ‘single allele’ (for V and J), based on the highest per
cent of identity of the V-REGION (‘V %’) compared with that of
the closest germline, and/or on the sequence length (thus, the
most complete V-REGION). Thus in Fig. 4a, the ‘IMGT
clonotype (AA)’ #17081, with an Exp. ID ‘13915-MIDAB_all’,
has a unique rearrangement ‘TRBV20-1*02F – TRBD1*01F
Title MIDA+MIDB
Homo sapiens
TRB
Sequence average length (nt)
Filtered-in
(64, 238 sequences 41.84%)
(89,301 sequences 58.16%)
Filtered-out
F+ORF+in-frame P
Yes
0
0
255
431
441
328
311
407
395
–
PARAMETERS
IMGT/V-QUEST reference directory species
IMGT/V-QUEST reference directory receptor type or locus
IMGT/V-QUEST reference directory set
Search for insertions and deletions
Nb of nucleotides to add (or exclude) in 3′ of the V-
REGION for the evaluation of the alignment score 
Nb of nucleotides to exclude in 5′ of the V-REGION for
the evaluayion of the nb of mutations
RESULTS
Result category Nb of sequences
153,539
63,371
867
1,086
34,897
646
19
52,653
(53 with insertions and/or
deletions)
(24,621 with insertions and/or
deletions)
Total
‘1 copy’
‘More than 1’
Warnings
Unknown functionality
No junction
No J-GENE
No results
Figure 2 | IMGT/HighV-QUEST summary. This figure represents a screenshot from IMGT/HighV-QUEST online. The 153,539 sequences ‘MIDAþ
MIDB’ submitted for detailed statistical analysis correspond to the pooled results of the IMGT/HighV-QUEST jobs 50 reads ‘MIDA_all’ and 30 reads
‘MIDB_all’. Parameters used for these analyses are recalled in the top of the IMGT/HighV-QUEST ‘Summary’ table. The lower part of the table shows the
classification of the sequences in the ‘Results category’21.
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Figure 3 | TRB gene usage for genotype analysis. Histograms for the TRBV genes (a), TRBD genes (b) and TRBJ genes (c) display results from the ‘1
copy’ ‘single allele’ (for V and J) (58,958 sequences, average sequence length of 440nt, average V-D-J-REGION length of 335nt), which are the result output
from the IMGT/HighV-QUEST detailed statistical analysis performed on ‘MIDAþMIDB’. The histograms show the genes, per group, from 50 to 30 in the TRB
locus1, with the number of sequences shown in parentheses. The TRBV30 gene is located downstream of the TRBC2 gene in the opposite orientation of
transcription1. TRBD1 is upstream of TRBJ1-1 and TRBD2 upstream of TRBJ2-1 (ref. 1). The histograms of the TRBD and TRBJ genes are displayed separately,
owing to the differences of scale (sequences being assigned to 2 and 13 genes, respectively). These histograms and corresponding tables online allow a genotype
and haplotype identification if the sequences are obtained from a single individual, as in this study. They include rearranged sequences with in-frame and out-of-
frame junctions.
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Figure 4 | IMGT clonotype (AA) and (nt) characterization. This figure represents screenshots from IMGT/HighV-QUEST online. (a) IMGT clonotypes
(AA). ‘Exp. ID’ is the identifier of the ‘IMGT clonotype (AA)’ in the data set. The IMGT clonotype (AA) definition includes the names of the V, D, J genes
and alleles, the CDR3-IMGT length (AA), the CDR3-IMGT sequence (AA) and the anchors 104 and 118 of the junction ‘C, F’ (for 2nd-CYS 104 and J-PHE
F118 for V-BETA, respectively). ‘V%’ indicates the percentage identity of the V-REGION of the representative sequence with the closest germline
V-REGION, the sequence length in nucleotides is provided and a link gives access to the sequence in FASTA format; ’nb’ indicates the number of sequences
’1 copy’ and ’More than 1’ assigned to the clonotype, and the total. In the ‘IMGT clonotypes (nt)’ column, ‘Sequences file’ gives access to a file containing
the ’1 copy’ sequences assigned to a given IMGT clonotype (AA), in FASTA format. An asterisk (#17083) indicates an example of IMGT clonotype
(AA) with a TRBV20-1*02-TRBD1*01-TRBJ1-6*02 rearrangement as described in the genotype and haplotype identification. This figure shows a very small
part of the list of the 22,234 unique IMGT clonotypes (AA) identified in this case study. (b) IMGT clonotypes (nt). The nb of different CDR3-IMGT
(nt) indicates the nb of IMGTclonotypes (nt) for a given IMGTclonotype (AA) (for example, 2 for #17379). The CDR3-IMGTsequence (nt) is shown with
the nb of different nt (nb diff nt). ‘0’ indicates that the CDR3-IMGT (nt) is identical to that of the IMGT clonotype (AA) representative sequence. For
#17379, there is an IMGT clonotype (nt) with 1 nt difference (‘c’ instead of ‘t’ at the third position, compared with the CDR3-IMGT of the representative
sequence). #17379 also shows an example of ‘several alleles’ (for V and J) assigned to an IMGT clonotype (AA).
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– TRBJ1-1*01F’, with a CDR3-IMGT length (AA) of ‘12 AA’ and
a CDR3-IMGT sequence (AA) ‘SAPAEGGNTEAF’, and con-
served anchors 104 and 118 ‘C, F’ (recall of the filter). The IMGT
clonotype (AA) representative sequence has a V-REGION, which
is 100% identical to that of TRBV20-1*02 and a length of 479 nt.
Clonal diversity and clonal expression. In this study, 22,234
unique IMGT clonotypes (AA) were identified and a repre-
sentative sequence was assigned to each (Supplementary Fig. S1).
The ‘1 copy’ ‘single allele’ sequences not selected as representative
(25,153 sequences) were each then assigned to a characterized
IMGT clonotype (AA). These sequences differ from the repre-
sentative sequence by a different (usually shorter) length, and/or
by sequencing errors in the V-REGION (lower ‘V %’ of identity)
or in the J-REGION, and/or by nucleotide differences in
the CDR3-IMGT. These sequences with nucleotide differences
in the CDR3-IMGT are identified as ‘IMGT clonotypes (nt)’. The
nucleotide differences may be due to sequencing errors or, if this
can be proven experimentally, molecular convergence. A given
‘IMGT clonotype (AA)’ may have one or several ‘IMGT clono-
types (nt)’. Thus in Fig. 4b, the ‘IMGT clonotype (AA)’ #17379
has two ‘IMGT clonotypes (nt)’, as shown by the number (‘2’) of
different CDR3-IMGT sequences (nt) (‘Nb diff CDR3-IMGT
(nt)’).
The ‘1 copy’ ‘several alleles (or genes)’ sequences are also
assigned to an ‘IMGT clonotype (AA)’, provided that they have
the same CDR3-IMGT (AA) and the same V and J alleles of the
representative ‘IMGT clonotype (AA)’ among those proposed by
IMGT/HighV-QUEST (Fig. 4b). In our study, 2,052 ‘several
alleles (or genes)’ sequences could be assigned to an ‘IMGT
clonotype (AA)’ (Supplementary Fig. S1). The nb of sequences of
‘More than 1’ for each ‘1 copy’ assigned to an IMGT clonotype
(AA) is finally included (795 sequences).
Thus, by proceeding stepwise to assign sequences, the high
quality and specific characterization of the ‘IMGT clonotype
(AA)’ remain unaltered. For the first time, for NGS antigen
receptor data analysis, our standardized approach allows a clear
distinction and accurate evaluation between clonal diversity (nb
of ‘IMGT clonotypes (AA)’) and clonal expression (nb of
sequences assigned, unambiguously, to a given ‘IMGT clonotype
(AA)’). In our study, the 22,234 ‘IMGT clonotype (AA)’ (clonal
diversity) corresponded to 50,234 sequences (clonal expression),
which represented 78.2% of the filtered-in sequences
(Supplementary Fig. S1). These assignments are clearly described
and visualized in detail, so the user can check clonotypes,
individually. Indeed, the sequences of each ‘1 copy’ assigned to a
given ‘IMGT clonotype (AA)’ are available in ‘Sequences file’
(Fig. 4a,b). The user can easily perform an analysis of these
sequences online with IMGT/V-QUEST (up to 50 sequences,
selecting ‘Synthesis view display’ and the option ‘Search for
insertions and deletions’) and/or with IMGT/JunctionAnalysis
(up to 5,000 junction sequences), which provide a visual
representation familiar to the IMGT users.
Homo sapiens TRB normalized reference immunoprofiles. The
comparison of clonal diversity and expression results between
studies and experiments requires standards and as these do not
exist for NGS, we established Homo sapiens TRB normalized
reference immunoprofiles. For clonal diversity, immunoprofiles
were obtained by normalizing, to a total of 10,000 clonotypes, the
nb of IMGT clonotypes (AA) per TRB (V, D and J) gene (in
pink), from the values of 22,231 IMGT clonotypes (AA) (having
excluded three abnormal clonotypes, each one represented by a
unique sequence) (Fig. 5). For clonal expression, immunoprofiles
were obtained by normalizing to a total of 10,000 sequences, the
nb of sequences assigned to IMGT clonotypes (AA) per TRBV (in
green), TRBD (in red) and TRBJ (in yellow) gene, from the values
of the 50,231 assigned sequences per gene (Fig. 6). Normalized
values for clonal diversity and expression are reported for TRBV
(Supplementary Table S3), TRBD (Supplementary Table S4) and
TRBJ (Supplementary Table S5). These TRB normalized reference
immunoprofiles will be used to identify variations of interest
between the 12 sets (in preparation), despite the overall similarity
of the results obtained for the individual sets (an observation that
led us to build the normalized reference from the results of the
pooled sets). Similarly, the nb of IMGT clonotypes (AA) per
CDR3-IMGT length (Fig. 7a) and the nb of sequences assigned to
the IMGT clonotypes (AA) per CDR3-IMGT length (Fig. 7b)
were normalized for 10,000 clonotypes (from 22,231 clonotypes)
and for 10,000 sequences (from 50,231 sequences), respectively
(Supplementary Table S6). This normalized distribution of clo-
notypes and sequences per CDR3-IMGT length will be used for
comparison between the different sets (in preparation) or for
results comparison with other studies performed with the same
IMGT/HighV-QUEST standards.
IMGT clonotypes (AA) in different T cell subpopulations.
Analysing an immune response implies the ability to identify the
emergence of new IMGT clonotypes (AA) and track memory
clonotypes within T cell subpopulations. Whereas the overall
immunoprofile was similar between the 12 sets as indicated above,
this contrasted with the high diversity of the ‘IMGT clonotypes
(AA)’ sequences. Of the total of 22,231 IMGT clonotypes (AA)
(50,231 sequences), 21,164 (40,898 seq) were unique to a set, with
the following T cell subpopulation distribution: 6,234 clonotypes
(12,854 seq) unique to CD4 sets, 9,492 (16,074 seq) to CD4þ
sets and 5,438 (11,970 seq) to Treg sets. In contrast, 1,067 IMGT
clonotypes (AA) were common to 2–7 sets (9,237 seq). Among
these, 825 (6,525 seq) were common only to sets of the same T cell
subpopulation, whereas 242 (2,712 seq) were common to sets
between different T cell subpopulations, underlying the impor-
tance of studying clonotypes at the sequence level. The low
number of common clonotypes between different T cell sub-
populations at any given time point confirmed that the flow
cytometry separation was effective.
Only two IMGT clonotypes (AA) were found in seven sets and
were the only common clonotypes pre-vaccination in the three
T cell subpopulations. Common ‘IMGT clonotypes (AA)’ were
identified post-vaccination, either within a given T cell sub-
population between different time points d3, d8 and d26 (28
clonotypes (272 seq), of which 8 (95 seq) were in CD4 sets, 4
(36 seq) in CD4þ sets and 16 (141 seq) in Treg sets), or between
two T cell subpopulations (9 clonotypes (63 seq)), but no
common clonotypes could be identified between all three T cell
subpopulations at any time point post-vaccination. The clono-
types emerging after vaccination required more extensive
molecular characterization and analysis. This however is
associated with biological analysis, and beyond the scope of this
study. Therefore, we focused on the IMGT clonotypes (AA),
common at the four time points within a given T cell
subpopulation. Thus, 82 IMGT clonotypes (AA), namely 29, 11
and 42 in the CD4 , CD4þ and Treg sets, respectively, were
identified and followed individually. These IMGT clonotypes
(AA) used different TRBV genes and alleles (Fig. 8). Whereas
the TRBV gene and allele distribution differed between the three
T cell subpopulations, the pattern was strikingly similar within a
subpopulation at different time points. This supports the
reproducibility of the IMGT/HighV-QUEST determination of
the IMGT clonotypes (AA), between experiments, and impor-
tantly, means that if variability was observed (for example, in the
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case of CD4þ in Fig. 8), this warrants exploration for either
experimental bias or biological significance. The individual clonal
expression of the 82 common IMGT clonotypes (AA) within a
given T cell subpopulation could also be followed using the
IMGT/HighV-QUEST statistical analysis results, based on the nb
of sequences assigned to each at the four time points and
Homsap TRBV1 P
TRBV 0.00
0.00
0.00
0.00
0.00
0.00
500.00 1,000.00
3,000.002,000.00
2,000.00 3,000.00 4,000.00 5,000.00 6,000.00
1,000.00
1,000.00
500.00 1,000.00 1,500.00 2,000.00 2,500.00
500.00 1,000.00 1,500.00 2,000.00 2,500.00
1,500.00
4,000.00 5,000.00 6,000.00
2,000.00 2,500.00 (nb)
(nb)
(nb)
(nb)
(nb)
500.00 1,000.00 1,500.00 2,000.00 2,500.00 (nb)
Homsap TRBV2 F (F)
Homsap TRBV3-1 F (F)
Homsap TRBV4-1 F
Homsap TRBV5-1 F (F)
Homsap TRBV6-1 F
Homsap TRBV7-1 ORF
Homsap TRBV4-2 F (F)
Homsap TRBV6-2 F (P)
Homsap TRBV3-2 P (P)
Homsap TRBV4-3 F (F)
Homsap TRBV6-3 F
Homsap TRBV7-2 F (F)
Homsap TRBV6-4 F
Homsap TRBV7-3 F ORF (F)
Homsap TRBV5-3 ORF
Homsap TRBV9 F (F)
Homsap TRBV10-1 F [P]
Homsap TRBV11-1 F
Homsap TRBV12-1P
Homsap TRBV10-2 F [F]
Homsap TRBV11-2 F [F] (F)
Homsap TRBV12-2 P
Homsap TRBV6-5 F
Homsap TRBV7-4 F [P]
Homsap TRBV5-4 F [F]
Homsap TRBV6-6 F [F]
Homsap TRBV5-5 F [F]
Homsap TRBV6-7 ORF
Homsap TRBV7-6 F (F)
Homsap TRBV5-6 F
Homsap TRBV6-8 F
Homsap TRBV7-7 F (F)
Homsap TRBV5-7 ORF
Homsap TRBV6-9 F
Homsap TRBV7-8 F (F)
Homsap TRBV5-8 F (F)
Homsap TRBV7-9 F (F)
Homsap TRBV13 F (F)
Homsap TRBV10-3 F [F]
Homsap TRBV11-3 F (F)
Homsap TRBV12-3 F
Homsap TRBV12-4 F (F)
Homsap TRBV12-5 F
Homsap TRBV14-F (F)
Homsap TRBV15 F (F)
Homsap TRBV16 F P (F)
Homsap TRBV17 ORF
Homsap TRBV18 F
Homsap TRBV19 F (F)
Homsap TRBV20-1 F (F)
Homsap TRBV21-1P
Homsap TRBV23-1P
Homsap TRBV24-1F
Homsap TRBV25-1F
Homsap TRBV26 P
Homsap TRBV27 F
Homsap TRBV28 F
Homsap TRBV29-1 F (F)
Homsap TRBV30 F P (F)
Homsap TRBD1 F
Homsap TRBD2 F
Homsap TRBJ1-1 F
Homsap TRBJ1-2 F
Homsap TRBJ1-3 F
Homsap TRBJ1-4 F
Homsap TRBJ1-5 F
Homsap TRBJ1-6 F
Homsap TRBJ2-1 F
Homsap TRBJ2-2 F
Homsap TRBJ2-2 P ORF
Homsap TRBJ2-3 F
Homsap TRBJ2-4 F
Homsap TRBJ2-5 F
Homsap TRBJ2-6 F
Homsap TRBJ2-7 F ORF
TRBD
TRBJ
Figure 5 | Normalized histogram for Homo sapiens TRB clonal diversity. Histograms represent the nb of IMGT clonotypes (AA) per V, D and J genes
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normalized for 10,000 sequences, in the CD4 sets (Supplementary
Fig. S2a), CD4þ sets (Supplementary Fig. S2b) and Treg sets
(Supplementary Fig. S2c).
Discussion
Although NGS exhibits great potential for the analysis of the
immune repertoire, NGS data per se are still heavily biased owing
Homsap  TRBV1 P
Homsap  TRBV2 F (F)
Homsap  TRBV3-1 F (F)
Homsap  TRBV4-1 F (F)
Homsap  TRBV5-1 F (F)
Homsap  TRBV6-1 F
Homsap  TRBV7-1 ORF
Homsap  TRBV4-2 F (F)
Homsap  TRBV6-2 F (P)
Homsap  TRBV3-2 P (P)
Homsap  TRBV4-3 F (F)
Homsap  TRBV6-3 F
Homsap  TRBV7-2 F (F)
Homsap  TRBV6-4 F
Homsap  TRBV7-3 F ORF (F)
Homsap  TRBV5-3 ORF
Homsap  TRBV9-F (F)
Homsap  TRBV10 -1 F [P]
Homsap  TRBV1-11 F
Homsap  TRBV12-1 P
Homsap  TRBV10-2 F [F]
Homsap  TRBV11-2 F [F] (F)
Homsap  TRBV12-2 P
Homsap  TRBV6-5 F
Homsap  TRBV7-4 F [P]
Homsap  TRBV5-4 F (F)
Homsap  TRBV6-6 F (F)
Homsap  TRBV5-5 F (F)
Homsap  TRBV6-7 ORF
Homsap  TRBV7-6 F (F)
Homsap  TRBV5-6 F
Homsap  TRBV6-8 F
Homsap  TRBV7-7 F (F)
Homsap  TRBV5-7 ORF
Homsap  TRBV6-9 F
Homsap  TRBV7-8 F (F)
Homsap  TRBV5-8 F (F)
Homsap  TRBV7-9 F (F)
Homsap  TRBV13 F (F)
Homsap  TRBV10-3 F [F]
Homsap  TRBV11-3 F (F)
Homsap  TRBV12-3 F
Homsap  TRBV12-4 F (F)
Homsap  TRBV12-5 F [F]
Homsap  TRBV14-F (F)
Homsap  TRBV15-F (F)
Homsap  TRBV16-F P (F)
Homsap  TRBV17 ORF
Homsap  TRBV18 F
Homsap  TRBV19 F (F)
Homsap  TRBV20-1 F (F)
Homsap  TRBV21-1 P
Homsap  TRBV23-1 P
Homsap  TRBV24-1 F
Homsap  TRBV25-1 F
Homsap  TRBV26 P
Homsap  TRBV27 F
Homsap  TRBV28 F
Homsap  TRBV29-1 F (F)
Homsap  TRBV30 F P (F)
0.00 500.00 1,000.00 1,500.00 2,000.00 2,500.00 (nb)
0.00 (nb)
(nb)
(nb)
(nb)
(nb)
500.00 1,000.00 1,500.00 2,000.00 2,500.00
Homsap TRBD1 F
Homsap TRBD2 F
Homsap TRBJ1-1 F
Homsap TRBJ1-2 F
Homsap TRBJ1-3 F
Homsap TRBJ1-4 F
Homsap TRBJ1-5 F
Homsap TRBJ1-6 F
Homsap TRBJ2-1 F
Homsap TRBJ2-2 F
Homsap TRBJ2-2P ORF
Homsap TRBJ2-7 F ORF
0.00 500.00 1,000.00 1,500.00 2,000.00 2,500.00
0.00
0.00
0.00
500.00 1,000.00
1,000.00
1,000.00 2,000.00
2,000.00
3,000.00
3,000.00
4,000.00
4,000.00
5,000.00
5,000.00
6,000.00
6,000.00
1,500.00 2,000.00 2,500.00
Homsap TRBJ2-3 F
Homsap TRBJ2-4 F
Homsap TRBJ2-5 F
Homsap TRBJ2-6 F
Figure 6 | Normalized histogram for Homo sapiens TRB clonal expression. Histograms represent the nb of sequences assigned to IMGT clonotypes
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to experimental and methodological flaws from the sample
preparation, to TR transcript amplification, or to the sequencing
and interpretation of the results. In this study, we used a
combination of 50RACE, 454 and IMGT/HighV-QUEST for
standardized analysis of complete V domains, for genotype/
haplotype analysis, characterization of IMGT clonotypes (AA),
clonal diversity and clonal expression, and generation of immune
profiles in normal repertoires and during disease.
The 50RACE12,26 is reliable for TR repertoire analysis as shown
by the overall consistency of the clonotypic and expression
histograms of 12 different sets (corresponding to three T cell
subpopulations at four time points) and confirmed by the detection
of rearranged transcripts of in-frame pseudogenes (which may be
used as internal controls). Whereas the 50RACE PCR introduced
few errors, probably due to the use of high-fidelity polymerases and
low cycle numbers, recent studies established that the majority of
errors in TR deep sequencing occur during the solid-phase steps42.
Interestingly, IMGT/HighV-QUEST analysis detects and corrects
insertions and/or deletions, which represent current sequencing
errors found with 454 due to homopolymer hybridization. The
IMGT/HighV-QUEST functionality ‘Search for insertions and
deletions’ is provided by default owing to the high number of
indels observed in NGS data. This functionality is identical to that
created in IMGT/V-QUEST22,25 online, as an option for analysis of
sequences from leukaemic cells in which indels are frequent23.
Sequencing errors in the CDR3-IMGT are not corrected by IMGT/
HighV-QUEST, however our characterization of ‘IMGT clonotypes
(nt)’ highlights sequences with CDR3-IMGT nt differences for each
IMGT clonotype (AA).
With free public online access, IMGT/HighV-QUEST allows our
approach to be readily adaptable to other studies. IMGT/HighV-
QUEST analyses directly the fully rearranged IG and TR V-J
and V-D-J sequences, without the need of computational assembly.
IMGT/HighV-QUEST is a generic tool that allows analysis of
IG and TR of different species, including identification of new allele
IG and TR polymorphisms and analysis of IG somatic hypermuta-
tions. Therefore, IMGT/HighV-QUEST requires NGS methodol-
ogy, which provides sufficiently long and reliable sequences
encompassing directly the V domain. The current average read
length of 454 sequencing isB400nt (431 nt for the ‘1 copy’ in this
study).
A major feature of our work was to define and characterize
‘IMGT clonotype (AA)’ to determine their nb (clonal diversity)
and to identify the nb of sequences assigned to each ‘IMGT
clonotype (AA)’ (clonal expression). This requires several steps in
the IMGT/HighV-QUEST statistical analysis. First, IMGT
clonotypes (AA) are identified among the ‘1 copy’ with in-frame
junctions, conserved anchors 104 and 118 (‘C, F’ for 2nd-CYS
and V-BETA J-PHE, respectively), V and J functional or ORF,
‘single allele’ (for V and J). Their characterization includes the
identification of the rearranged TRBV and TRBJ gene and allele at
the nucleotide level by IMGT/HighV-QUEST, and that of a
unique CDR3-IMGT (AA) sequence. As a given clonotype may
be identified in sequences that differ in length and/or contain
sequencing errors, a representative sequence (highest percentage
identity of the V-REGION and longest sequence) and an
identifier are assigned to each IMGT clonotype (AA) identified
in a given data set. Second, the nb of sequences for an IMGT
clonotype (AA) (clonal expression) is obtained by aggregating to
the representative sequence the nb of sequences that are not
selected as representative. The ‘Sequences file’ of the IMGT
clonotypes (AA) allows a comparison of all the sequences
assigned to a given clonotype (AA). We demonstrate that
common IMGT clonotypes (AA) can be followed at different
time points between T cell subpopulations, revealing the
feasibility of a standardized approach for analysis of specific
clones in the immune response.
As a large number of antigens are implicated in any infection, it
is impossible to identify and simultaneously investigate all
antigen-specific T cells mobilized against a complex pathogen.
IMGT/HighV-QUEST is capable of quantitatively analysing
almost half a million (450,000) results of sequences, simulta-
neously. With more than 530 columns of results per sequence
(Supplementary Table S7), the nb of data analysed is 42 108,
and represents a genuine advance in standardized and high-
quality TR repertoire analysis. It is becoming increasingly
apparent that the nature of the T cell repertoire deployed during
an immune response can directly affect disease outcomes7,9,43–46.
As such, new tools and a standardized methodology (as presented
in this case study) capable of dissecting the TR repertoire in a
rapid, detailed and comprehensive fashion will be helpful in
uncovering new immunopathological associations and accelerate
knowledge of basic TR repertoire biology.
Presently, TR repertoire investigation is limited by two
polarizing challenges. At one end, high-throughput sequencing
alone cannot correlate a clonotype with its functional parameters.
At the other end, Sanger sequencing of sorted cells has low
throughput and the method depends on prior knowledge of the
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Figure 7 | Normalized histogram for Homo sapiens TRB CDR3-IMGT
length. (a) The histogram represents the nb of IMGT clonotypes (AA) per
CDR3-IMGT length. Values for clonal diversity (nb of IMGT clonotypes
(AA) per CDR3-IMGT length) were normalized for 10,000 IMGT
clonotypes (AA). (b) The histogram represents the nb of sequences
assigned to IMGT clonotypes (AA) per CDR3-IMGT length. Values for
clonal expression (nb of sequences assigned to IMGT clonotypes (AA) per
CDR3-IMGT length) were normalized for 10,000 sequences assigned to
IMGT clonotypes (AA). These TRB clonal diversity and expression
repertoires per CDR3-IMGT length were from a single individual and had no
detectable bias. They represent TRB immunoprofile references for
comparative analysis of TR V-BETA clonal diversity and expression
repertoires per CDR3-IMGT length in studies performed with the same
IMGT/HighV-QUEST standards.
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antigen and/or the antigen-specific cells, thus often missing many
antigen-specific populations. Combining high-throughput TR
immunoprofiling using IMGT/HighV-QUEST analysis with cell
identity-oriented approaches will bring genuine advances in TR
repertoire studies in health and disease.
Methods
Ethics statement. The study was approved by the Alfred Hospital Research Ethics
Committee and the Victorian Department of Human Services Human Research
Ethics Committee. Written informed consent was obtained from the volunteer.
Cells and RNA. A 45-year-old healthy male Caucasoid volunteer (HLA- A*0201/
*3002, B*1501/*1801, C*0303/*0501, DRB1*0301/*0401, DQB1*0302/*0201) was
vaccinated with H1N1 vaccine (Panvax H1N1 Vaccine, CSL), and blood samples
were collected before vaccination and on days 3, 8 and 26 post-vaccination. PBMC
at each time point were depleted of CD14þ and CD19þ cells using MACS
(Miltenyi Biotec), stained for CD4, CD3, CD25 and CD127 surface expression
(fluorochrome-conjugated monoclonal antibodies from BD Biosciences) and then
sorted into three T cell subpopulations: regulatory T cells (‘Treg’, with a phenotype
CD3þCD25þCD127 /lo)27 and conventional T cells CD3þCD4þ (‘CD4þ ’)
and CD3þCD4 (‘CD4 ’) using FACSAria (BD Biosciences) (Fig. 1a). Treg
cells27–30, which represent a minor subpopulation (B5% ) within circulating
T cells (or B2% of PBMC) were included in the analysis to evaluate if the
technique works for both abundant T cell subpopulations (e.g., CD4þ ) as well as
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Figure 8 | TRBV genes and alleles in common IMGT clonotypes (AA). As a control of the feasibility of following IMGT clonotypes (AA) common
to different sets, the distribution of the TRBV genes and alleles was taken as an indicator. The 82 IMGTclonotypes (AA) that were common at the four time
points within a given T cell subpopulation were selected (29 in the CD4 sets, 11 in the CD4þ sets and 42 in the Treg sets). The percentage of the
nb of sequences assigned to the IMGT clonotypes (AA) and characterized by their TRBV gene and allele, normalized for 10,000 sequences, is graphically
represented with four pie graphs for the four time points (pre-vaccination (Pre), post-vaccination at day 3 (d3), day 8 (d8) and day 26 (d26)), displayed
vertically per T cell subpopulation (CD4 , CD4þ , Treg).
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small subpopulations. RNA was immediately extracted from sorted cells using
RNeasy minikit (Qiagen). In one experiment, DNA was extracted from CD14þ
and CD19þ cells, and was subsequently used in high-resolution HLA class I and II
typing29.
Amplicon library construction. The concentration of RNA was determined using
a NanoDrop ND-8000 spectrophotometer and B200 ng RNA was used for each
library. TRB transcripts were amplified using 50RACE PCR12,26 because this
strategy provides an unbiased amplification of full, rearranged V-D-J sequences.
We chose to amplify mRNA over rearranged genomic DNA to obtain sufficiently
long sequences with complete V domains, by avoiding the intervening sequence
between J and C. A total of 12 libraries were constructed, corresponding to the 12
blood samples (three T cell subpopulations  four time points), using established
protocols12,13 with minor modifications. In brief, a 50RACE PCR was conducted
using the SMARTer RACE cDNA Amplification Kit (Clontech Laboratories)
according to the manufacturer’s instructions. The extension time for the first-
strand cDNA synthesis was 90min at 42 C followed by 15-min inactivation at
70 C. The first-round PCR was achieved using Phusion Hot-Start DNA
Polymerase (Finnzymes), a template-switching oligonucleotide (TSO), a universal
primer mix (supplied in the above SMARTer RACE cDNA amplification kit), along
with the TRBC gene-specific reverse primer, 50-TTCTGATGGCTCAAACAC-30
(codon positions 11-6, IMGT unique numbering), which aligns to both TRBC1 and
TRBC2 genes1,31 (IMGT Repertoire, http://www.imgt.org). The cycling conditions
were: 30 s denaturation at 98 C, 26 cycles of 10 s at 98 C, 10 s at 55 C and 20 s at
72 C, plus a final extension for 5min at 72 C. The reaction products were purified
using QIAquick columns (Qiagen). The purified DNA fragment was loaded on a
1.5% low melting temperature agarose gel, and a band corresponding to a 500- to
650-bp product was excised and purified using the QIAquick Gel Extraction Kit
(Qiagen). A second-round PCR was performed on a fraction of the first-round
reaction. This step incorporated Roche forward and reverse linker primers to
enable the sequencing and the Multiplex Identifier (MID) or barcodes (MID1–
MID8, MID10–MID12 and MID14) to distinguish the different cell fractions and
time points (454 Sequencing Technical bulletin TCB N013-2009, August 2009).
The product of the second-round PCR was purified as described above, and
quantified using PicoGreen reagent (Invitrogen). Finally, an equal amount (100 ng)
of cDNA from each of the 12 libraries was pooled to obtain the final amplicon
library, which represents the complete collection of TRBV transcripts sampled
from this donor (Fig. 1b).
Sequencing and initial data processing. Sequencing was performed on a 14
PicoTiterPlate by the Australian Genome Research Facility using the 454 Genome
Sequencer FLX (GSFLX) Titanium (Roche). Initial data processing was performed
using the manufacturer’s software, which included the removal of low quality and
erroneous sequences as determined by the standard filters of the Roche amplicon
signal-processing pipeline. Sequences were assigned to samples based on
incorporated barcodes, and read orientation was determined by the presence or
absence of the sequence corresponding to the TSO used in the SMARTer RACE.
Sequence segments corresponding to the adapters, barcodes and TSO were
removed during this process. Quality control was conducted by spiking the
amplicon library using classical cloning and sequencing methods7,11.
Repertoire analysis using IMGT/HighV-QUEST. The ‘final 454-output’ reads
were submitted online to IMGT/HighV-QUEST21,22. The full capacity of IMGT/
HighV-QUEST includes analysis of V-J and V-D-J rearranged sequences (up to
150,000 per job) and statistical analysis (on results of up to 450,000 sequences)
(http://www.imgt.org, version July 2012). The IMGT/HighV-QUEST21 submission
page allows users to submit a file containing up to 150,000 sequences and to select
options (equivalent to those of IMGT/V-QUEST22–25) for the results display. The
results are provided in a downloadable main folder with 11 files21 (Supplementary
Table S7) in CSV format (results equivalent to those of the Excel file from IMGT/
V-QUEST online22–25), and one folder with the individual files (up to 150,000) of
all the sequence results21. For each analysed sequence, the results in those
individual files are identical to those that could be obtained from IMGT/V-QUEST
online (in display option ‘Text’ of ’Detailed view’22–25). Text and CSV formats
facilitate statistical studies for further interpretation and information extraction.
Before IMGT/HighV-QUEST analysis, the users can evaluate the quality of their
sequences by checking the results obtained with IMGT/V-QUEST on a few
sequences.
In a second online step, the users can submit the results of one or several jobs
(up to 450,000 results) for statistical analysis. The IMGT/HighV-QUEST
‘Summary’ table of the statistical analysis provides information in Results
categories that are either filtered in (‘1 copy’, ‘More than 1’) or filtered out
(‘Warnings’, ‘Unknown functionality’, ‘No results’)21. The number of sequences in
the different categories provides the users with an immediate indication of data
reliability.
Before the final results, statistical analyses were also performed on ‘MIDA_all’
and ‘MIDB_all’ separately, and on the 50 reads and 30 reads separately of each of the
12 samples for the purpose of data evaluation. The 50 and 30 reads were pooled
to overcome the limitation of 454 sequencing, which does not provide genuine
‘bi-directional’ sequences. Indeed, the 50 reads and 30 reads are generated
independently in separate wells, and the comparison of the IMGT/HighV-QUEST
statistical analysis performed on the 50 or 30 reads, separately or pooled, confirmed
the necessity of pooling to avoid losing information.
Genotype and haplotypes identification. The genotype and haplotypes were
deduced from the IMGT/HighV-QUEST statistical analysis performed on all
pooled sets (‘MIDAþMIDB’) on the results category ‘1 copy’ ‘single allele’ (for V
and J).
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